Canary Staked Inj ETF (INJC) closed at $23.62 on November 12, 2026, down 6.1% from the previous close, on volume of 2,534 shares (30-day average 5,064).
Data as of November 12, 2026.
No headlines found.
No press releases found.
No news found.
The Trust's investment objective is to seek to provide exposure to the price of Injective ("INJ") held by the Trust, less the expenses of the Trust's operations and other liabilities. A secondary investment objective is for the Trust to earn additional INJ through its participation in the staking program (the "Staking Program") administered by the Sponsor, in which staking rewards will be earned through the validation of transactions on the Injective proof-of-stake blockchain (the "Injective Network"). In seeking to achieve its investment objectives, the Trust will hold INJ and establish its net asset value ("NAV") by reference to the CoinDesk Injective Benchmark Extended 60m NY Rate ("Pricing Benchmark"). The Trust is a passive investment vehicle that does not seek to generate returns beyond tracking the price of INJ, with staking. The Trust intends to provide direct exposure to the price of INJ held by the Trust with BitGo Bank & Trust, N.A. ("BitGo" or the "Custodian").
Canary Staked Inj ETF trades on the NASDAQ stock market under the symbol INJC.
As of November 12, 2026, INJC stock price declined to $23.62 with 2,534 million shares trading.
INJC has a market cap of $14.17 million. This is considered a Sub-Micro Cap stock.
INJC support price is $24.45 and resistance is $25.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INJC shares will trade within this expected range on the day.
